Total Liabilities Equity - Genfit SA (NASDAQ:GNFT) - Alpha Spread

Genfit SA
NASDAQ:GNFT

Watchlist Manager
Genfit SA Logo
Genfit SA
NASDAQ:GNFT
Watchlist
Price: 4.19 USD -3.46% Market Closed
Market Cap: 209.5m USD
Have any thoughts about
Genfit SA?
Write Note

Genfit SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genfit SA
Total Liabilities & Equity Peer Comparison

Comparables:
VLA
NANO
IPH
ALERS
OSE

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Genfit SA
NASDAQ:GNFT
Total Liabilities & Equity
€173.9m
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
20%
Valneva SE
PAR:VLA
Total Liabilities & Equity
€466.6m
CAGR 3-Years
-14%
CAGR 5-Years
13%
CAGR 10-Years
7%
Nanobiotix SA
PAR:NANO
Total Liabilities & Equity
€93.9m
CAGR 3-Years
-11%
CAGR 5-Years
15%
CAGR 10-Years
29%
Innate Pharma SA
PAR:IPH
Total Liabilities & Equity
€151.5m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
4%
Eurobio Scientific SA
PAR:ALERS
Total Liabilities & Equity
€316.3m
CAGR 3-Years
22%
CAGR 5-Years
35%
CAGR 10-Years
25%
OSE Immunotherapeutics SA
PAR:OSE
Total Liabilities & Equity
€82.1m
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is Genfit SA's Total Liabilities & Equity?
Total Liabilities & Equity
173.9m EUR

Based on the financial report for Dec 31, 2023, Genfit SA's Total Liabilities & Equity amounts to 173.9m EUR.

What is Genfit SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
20%

Over the last year, the Total Liabilities & Equity growth was -19%. The average annual Total Liabilities & Equity growth rates for Genfit SA have been -4% over the past three years , -5% over the past five years , and 20% over the past ten years .

Back to Top